Literature DB >> 17694769

Tuberculosis treatment outcomes in State Hospital, Osogbo, southwestern Nigeria: a four year review.

B E Egbewale1, S S Taiwo, O O Odu, O A Olowu, S O Sobaloju.   

Abstract

BACKGROUND: A retrospective review of all cases of tuberculosis (TB) enrolled in the directly observed treatment-short course chemotherapy (DOT-SCC) between June 2000 and June 2004 at a General Hospital in Southwestern Nigeria was undertaken. The aim is to determine treatment outcomes and ascertain the effectiveness of the programme for TB control.
METHODOLOGY: Case registers of all TB patients enrolled were reviewed and data obtained analyzed by statistical methods.
RESULTS: A total of 879 TB patients (467 males, 412 females; M: F ratio 1.13:1) aged 1 to 80 years (mean age 33.0 +/- 14.0 years) were enrolled. The disease was pulmonary in 98.4% and extrapulmonary in 1.6%. Seven hundred and thirty four (83.6%) patients complied with the DOTS-SCC regimen, 127 (14.4%) defaulted while 18 (2%) transferred out. The overall treatment success rate was 76.3% while 3.8% had treatment failures. Outcome was not significantly affected by types of TB lesion (P = 0.1103), patient category (P = 0.4968), age (P = 0.7198), gender (P = 0.1726) or smear positivity (P = 0.5497).
CONCLUSION: Although the currently advocated DOT-SCC regimen achieved a high success rate in this locality, it fell below the 85% recommended target. There is need to step up health education campaign on compliance with therapy and aggressively follow up defaulters to forestall the emergence of multidrug resistant M. tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17694769     DOI: 10.4314/njm.v16i2.37298

Source DB:  PubMed          Journal:  Niger J Med        ISSN: 1115-2613


  1 in total

1.  Treatment Outcome of Tuberculosis Patients Registered at DOTS Centre in Ogbomoso, Southwestern Nigeria: A 4-Year Retrospective Study.

Authors:  Olarewaju Sunday; Olanrewaju Oladimeji; Folorunso Ebenezer; Babatunde Akintunde; Temitayo-Oboh Abiola; Abdulsalam Saliu; Oluwatoyin Abiodun
Journal:  Tuberc Res Treat       Date:  2014-09-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.